Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Conducting Quality Audits in Injectable Manufacturing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Conducting Quality Audits in Injectable Manufacturing – V 2.0

Standard Operating Procedure for Conducting Quality Audits in Injectable Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/083/2025
Supersedes SOP/SIM/083/2022
Page No. Page 1 of 15
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To define the procedure for conducting internal quality audits within the sterile injectable manufacturing facility to assess compliance with cGMP, company standards, and regulatory expectations, and to identify areas of improvement.

2. Scope

This SOP applies to all departments and

operations within the sterile injectable manufacturing facility that are subject to internal audits, including production, QA, QC, engineering, and warehouse operations.

3. Responsibilities

  • Lead Auditor: Plans, conducts, and reports audits; ensures objectivity and compliance with audit scope.
  • Audit Team Members: Participate in audit execution and documentation.
  • Auditees: Provide required documentation, access, and clarifications during audits.
  • QA Head: Reviews audit findings and ensures implementation of corrective and preventive actions (CAPA).
See also  Sterile Injectable Manufacturing: SOP for Cleaning and Maintenance of Dispensing Equipment - V 2.0

4. Accountability

The Head – Quality Assurance is accountable for ensuring that internal audits are conducted periodically and that all observations are addressed through timely CAPA implementation.

5. Procedure

5.1 Audit Planning

  1. Prepare an Annual Internal Audit Calendar (Annexure-1).
  2. Define audit scope, criteria, objectives, and schedule.
  3. Assign lead auditor and audit team ensuring independence from auditee departments.

5.2 Audit Execution

  1. Conduct opening meeting to brief the audit plan to department heads.
  2. Perform physical inspection, document review, and personnel interviews.
  3. Record all observations in Audit Observation Sheet (Annexure-2).
  4. Classify findings as critical, major, or minor based on potential risk to product quality.

5.3 Audit Reporting

  1. Prepare an Audit Summary Report (Annexure-3) within 5 working days of audit completion.
  2. Send report to relevant stakeholders for review and CAPA initiation.
See also  Sterile Injectable Manufacturing: SOP for Operation of Laminar Flow Cabinets during Aseptic Processing - V 2.0

5.4 Corrective and Preventive Actions (CAPA)

  1. Departments submit CAPA plans within 10 working days using CAPA Form (Annexure-4).
  2. QA verifies adequacy and implementation of CAPA during follow-up audits.

5.5 Audit Closure

  1. Once all CAPAs are verified and closed, update the Audit Closure Status Log (Annexure-5).
  2. Conduct a closing meeting and document audit closure in the audit report.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practices
  • CAPA: Corrective and Preventive Action
  • QA: Quality Assurance
  • QC: Quality Control

7. Documents

  1. Annual Audit Calendar – Annexure-1
  2. Audit Observation Sheet – Annexure-2
  3. Audit Summary Report – Annexure-3
  4. CAPA Form – Annexure-4
  5. Audit Closure Status Log – Annexure-5

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211 – GMP Requirements
  • WHO TRS 986 Annex 2 – GMP for Sterile Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance
See also  Manufacturing Operations: SOP for Sterile Handling of Ampoules during Manufacturing - V 2.0

11. Annexures

Annexure-1: Annual Audit Calendar

Department Scheduled Audit Date Lead Auditor
Production 10/01/2025 Sunita Reddy
Warehouse 15/03/2025 Rajesh Kumar

Annexure-2: Audit Observation Sheet

Observation No. Description Category Auditor
OBS-01 Incomplete BMR entries Major Sunita Reddy

Annexure-3: Audit Summary Report

Audit Date 12/06/2025
Audited Department Filling
No. of Observations 3
Report Prepared By Rajesh Kumar

Annexure-4: CAPA Form

Observation No. Corrective Action Preventive Action Responsible
OBS-01 Train operators on documentation Introduce BMR checklist Anita Mehta

Annexure-5: Audit Closure Status Log

Audit ID Closure Date Verified By Status
AUD-2025-01 25/06/2025 QA Officer Closed

Revision History

Revision Date Revision No. Details Reason Approved By
01/02/2022 1.0 Initial version New SOP implementation QA Head
18/06/2025 2.0 Updated CAPA workflow and annexures Annual review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Analytical Method Development: SOP for DSC Method for Thermal Behavior Analysis – V 2.0
Next Post: Gel Manufacturing: SOP for Analyzing Stability Data for Gel Formulations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version